Costello Medical provides scientific support in analysing, interpreting, and communicating clinical and health economic data for pharmaceutical companies, medical device manufacturers, and healthcare organisations. Cross functional teams deliver evidence development, value and access strategies, medical communications, and health policy across rare diseases, gene therapy, and medical technology. Founded in 2008, the company has grown to over 500 employees in eight global offices. Independently owned with no external shareholders, it maintains B Corp certification and has twice received the King's Award for Enterprise in International Trade, reflecting commitment to exceptional service and trusted partnerships across the healthcare sector.
500
Team Members
2008
Founded
Consulting
Sector
Hybrid
Work Environment
A world where healthcare decisions are informed by rigorous evidence that improves patient outcomes and advances medical understanding across all communities.
Costello Medical builds trusted partnerships across the healthcare sector by delivering exceptional scientific support in the analysis, interpretation, and communication of clinical and health economic data.